| Measuring normal and pathological anxiety-like behaviour in mice: a review C Belzung, G Griebel Behavioural brain research 125 (1-2), 141-149, 2001 | 1242 | 2001 |
| Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment … G Griebel, J Simiand, C Serradeil-Le Gal, J Wagnon, M Pascal, B Scatton, ... Proceedings of the National Academy of Sciences 99 (9), 6370-6375, 2002 | 611 | 2002 |
| Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal A Surget, M Saxe, S Leman, Y Ibarguen-Vargas, S Chalon, G Griebel, ... Biological psychiatry 64 (4), 293-301, 2008 | 606 | 2008 |
| Mouse defensive behaviors: pharmacological and behavioral assays for anxiety and panic DC Blanchard, G Griebel, RJ Blanchard Neuroscience & Biobehavioral Reviews 25 (3), 205-218, 2001 | 604 | 2001 |
| 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research G Griebel Pharmacology & therapeutics 65 (3), 319-395, 1995 | 551 | 1995 |
| Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders A Holmes, M Heilig, NMJ Rupniak, T Steckler, G Griebel Trends in pharmacological sciences 24 (11), 580-588, 2003 | 518 | 2003 |
| Antidepressants recruit new neurons to improve stress response regulation A Surget, A Tanti, ED Leonardo, A Laugeray, Q Rainer, C Touma, ... Molecular psychiatry 16 (12), 1177-1188, 2011 | 517 | 2011 |
| Differences in anxiety-related behaviours and in sensitivity to diazepam in inbred and outbred strains of mice G Griebel, C Belzung, G Perrault, DJ Sanger Psychopharmacology 148, 164-170, 2000 | 486 | 2000 |
| Risk assessment as an evolved threat detection and analysis process DC Blanchard, G Griebel, R Pobbe, RJ Blanchard Neuroscience & Biobehavioral Reviews 35 (4), 991-998, 2011 | 452 | 2011 |
| Blockade of CRF1 or V1b receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression R Alonso, G Griebel, G Pavone, J Stemmelin, G Le Fur, P Soubrie Molecular psychiatry 9 (3), 278-286, 2004 | 419 | 2004 |
| The Mouse Defense Test Battery: pharmacological and behavioral assays for anxiety and panic DC Blanchard, G Griebel, RJ Blanchard European journal of pharmacology 463 (1-3), 97-116, 2003 | 343 | 2003 |
| 50 years of hurdles and hope in anxiolytic drug discovery G Griebel, A Holmes Nature reviews Drug discovery 12 (9), 667-687, 2013 | 332 | 2013 |
| SSR180711, a novel selective α7 nicotinic receptor partial agonist:(II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia P Pichat, OE Bergis, JP Terranova, A Urani, C Duarte, V Santucci, ... Neuropsychopharmacology 32 (1), 17-34, 2007 | 310 | 2007 |
| Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonist, rimonabant … C Cohen, G Perrault, G Griebel, P Soubrié Neuropsychopharmacology 30 (1), 145-155, 2005 | 304 | 2005 |
| The free-exploratory paradigm: an effective method for measuring neophobic behaviour in mice G Griebel, C Belzungz, R Misslin, E Vogel Behavioural pharmacology 4, 637-644, 1993 | 301 | 1993 |
| Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents G Griebel, J Stemmelin, B Scatton Biological psychiatry 57 (3), 261-267, 2005 | 295 | 2005 |
| 4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl) ethyl] 5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine hydrochloride (SSR125543A), a potent … G Griebel, J Simiand, R Steinberg, M Jung, D Gully, P Roger, M Geslin, ... Journal of Pharmacology and Experimental Therapeutics 301 (1), 333-345, 2002 | 286 | 2002 |
| Differentiation of anxiolytic and panicolytic drugs by effects on rat and mouse defense test batteries RJ Blanchard, G Griebel, JA Henrie, DC Blanchard Neuroscience & Biobehavioral Reviews 21 (6), 783-789, 1997 | 284 | 1997 |
| Characterization of (2S, 4R)-1-[5-chloro-1-[(2, 4-dimethoxyphenyl) sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2, 3-dihydro-1H-indol-3-yl]-4-hydroxy-N, N-dimethyl-2-pyrrolidine … C Serradeil-Le Gal, J Wagnon, J Simiand, G Griebel, C Lacour, G Guillon, ... Journal of Pharmacology and Experimental Therapeutics 300 (3), 1122-1130, 2002 | 265 | 2002 |
| Effects of the selective nonpeptide corticotropin-releasing factor receptor 1 antagonist antalarmin in the chronic mild stress model of depression in mice C Ducottet, G Griebel, C Belzung Progress in Neuro-Psychopharmacology and Biological Psychiatry 27 (4), 625-631, 2003 | 261 | 2003 |
